| 
				È«Ãñ½¡¿µ±£ëUËŽÆ·½o¸¶Ò޶¨ / ½¡±£´a¼°½¡±£ƒr | 
		 
		
			| 
				See related Cefazolin (Oriental) inj[Î÷ÈAüqËØ ×¢Éä„©] information | 
		 
		
			| 
				  | 
		 
		
			| 
				ÑuÔìÉÌ | 
			
				Oriental | 
		 
		
			| 
				´úÀí/½›äNÉÌ | 
			
				Oriental | 
		 
		
			| 
				³É·Ý | 
			
				Cefazolin Na 
				Click to view cefazolin information | 
		 
		
			| 
				ßm‘ªÖ¢¼°ÓÃÁ¿ | 
			
				For details on therapeutic uses and relevant dosage relating to the cefazolin ... Click to view cefazolin | 
		 
		
			| 
				ÃÀ‡øÊ³Æ·ËŽÎï¹ÜÀí¾ÖÖ®‘ÑÔеȼ‰ | 
			
				
				Category B: Either animal-reproduction studies have not demonstrated a foetal risk but there are no controlled studies in pregnant women or animal-reproduction studies have shown an adverse effect (other than a decrease in fertility) that was not confirmed in controlled studies in women in the 1st trimester (and there is no evidence of a risk in later trimesters). | 
		 
		
			| 
				„©ÐÍ/°üÑb | 
		 
		
			
				
					
						
							| 
								„©ÐÍ | 
							
								°üÑb | 
							
								ˆDƬ | 
						 
						
							| 
								Cefazolin (Oriental) ×¢Éä„©  | 
							
								
									
										
											| 
												Cefazolin (Oriental) 500 mg x 1's | 
										 
									
								 
							 | 
						 
					
				 
				 | 
		 
		
			
				
					
						
							
								
									
										
											| 
												Manufacturer: | 
											
												Oriental | 
										 
										
											| 
												Distributor: | 
											
												Oriental 
												  | 
										 
									
								 
							 | 
						 
					
				 
			 | 
		 
	
 
   
    | ÒÔÏÂÊÇ¡°È«ÇòÒ½Ò©¡±Ïêϸ×ÊÁÏ | 
   
   
     | 
     | 
   
  |